# Acute Impact of Cardiac Resynchronization on Vascular Function (RVA-CRT)

> **NCT04379401** · NA · COMPLETED · sponsor: **Andreas Flammer** · enrollment: 35 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Cardiac Resynchronization Therapy (ON vs. OFF)

## Key facts

- **NCT ID:** NCT04379401
- **Lead sponsor:** Andreas Flammer
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2023-06-20
- **Final completion:** 2023-06-20
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04379401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04379401, "Acute Impact of Cardiac Resynchronization on Vascular Function (RVA-CRT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04379401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*